Genmab A/S (GMAB)
NASDAQ·Healthcare·Biotechnology
$26.78
+0.53%
Mkt Cap $16.79B
Next Earnings
In 8 daysThu, May 7, 2026
EPS Estimate
$0.15
4 analysts
Revenue Estimate
$905.86M
Last quarter: missed by -89.13% on EPS, -0.76% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$16.79B
P/E
—
Fwd P/E
20.39
P/S
0.88
Rev TTM
—
EPS TTM
$63.07